Dr Reddy's Shares Plunge 7% After Disappointing Q3 Earnings
The stock dropped 6.65 per cent to Rs 1,203.60 on the BSE.
At the NSE, it tanked 6.66 per cent to Rs 1,203.50.
Dr Reddy's Laboratories on Thursday said its consolidated net profit increased 2 per cent to Rs 1,413 crore in the third quarter ended December 31, 2024.
The Hyderabad-based drug major had reported a profit of Rs 1,379 crore for the October-December period of last fiscal.
Revenue increased to Rs 8,359 crore from Rs 7,215 crore a year ago, Dr Reddy's Laboratories said in a statement.
You May Like To Read
MORE NEWS
TCS announced Sudeep Kunnumal as the new Chief Human Resources Officer, succeeding...
The ICAI may review IndusInd Bank's financial statements after discrepancies in...
India's commerce ministry has assured exporters of protection against US tariff...
HDFC Mutual Fund has increased its stake in IndusInd Bank to over 5%, buying 15.92 lakh...
Tamil Nadu Finance Minister Thangam Thennarasu will present the fifth Budget of the DMK...
Citi report analyzes Starlink's tie-ups with Jio and Bharti, suggesting satcom services...
Ajay Singh, SpiceJet's MD, has sold nearly 1% stake in the budget airline for Rs 52...
LG Electronics India gets Sebi's nod to float a Rs 15,000 crore IPO, marking the second...
Patanjali Ayurved and DS Group will acquire Magma General Insurance from Sanoti...
Canara Bank proposes to raise up to Rs 4,000 crore through Basel III compliant Tier II...